Editor LSA

Movers to Watch - Federal National Mortgage Association (OTCBB:FNMA), Federal Home Loan Mortgage Corp (OTCBB:FMCC), KV Pharmaceutical Co, Sanborn Resources Ltd

 

Lewes, DE -- (SBWIRE) -- 08/07/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Federal National Mortgage Association (OTCBB:FNMA), Federal Home Loan Mortgage Corp (OTCBB:FMCC), KV Pharmaceutical Co (OTCMKTS:KVPHQ), Sanborn Resources Ltd (OTCBB:SANB)

Federal National Mortgage Association (OTCBB:FNMA) increased +3.31% at the price of $1.56 recently on a traded volume of 13.64 million shares, in comparison to 27.12 million shares of average trading volume. So far this year, the stock is down over +507.84%.

The company has a total market capitalization of $2.67 billion and its total outstanding shares are 89 million. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States.

For How Long FNMA’s Gloss will Attract Investors? Find out via this report

Federal Home Loan Mortgage Corp (OTCBB:FMCC) soared +1.43% at the trading price of $1.42 on a traded volume of 6.54 million shares till now, whereas its average trading volume is 10.18 million shares. In the last three months, the stock is up +73.59%. The Intra-day range for the stock is $1.35 and $1.45. Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States. It operates in three segments: Single-Family Guarantee, Investments, and Multifamily.

For How Long FMCC will fight for Profitability? Read This Trend Analysis report

KV Pharmaceutical Co (OTCMKTS:KVPHQ) dropped -23.16% at the $0.192 recently. So far in three months, the stock is down -39.97%. The 52-week range for the stock is $0.03 and $0.25. Its introductory price for the day was $0.25, with the overall traded volume of 22.70 million shares. K-V Pharmaceutical Company operates as a specialty branded pharmaceutical marketing company primarily focusing on women?s health care in the United States.

Why Should Investors Buy KVPHQ After the Recent Fall? Just Go Here and Find Out

Sanborn Resources Ltd (OTCBB:SANB), after opening its shares at the price of $0.33, dropped -24.706% , its recent trading price was $0.250 for the day. The stock moved on a traded volume of 1.34 million shares, in comparison to 1.04 million shares of average trading volume.

The 52-week range for the stock is $0.12 and $0.79. Its introductory price for the day was $0.33. Sanborn Resources, Ltd., a development stage company, focuses on the evaluation of opportunities in mining and minerals in Brazil. The company was formerly known as Universal Tech Corp. and changed its name to Sanborn Resources, Ltd. in March 2013. Sanborn Resources, Ltd. was founded in 2011 and is based in West Palm Beach, Florida.

Will SANB Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/